These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9396196

  • 1. I-123-IDAB: a new tracer for scintigraphic visualisation of malignant melanoma.
    Lodewijks H, Everaert H, Hennekes R, Bossuyt A.
    Bull Soc Belge Ophtalmol; 1996; 263():109-13. PubMed ID: 9396196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
    Everaert H, Bossuyt A, Flamen P, Mertens J, Franken PR.
    J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
    [Abstract] [Full Text] [Related]

  • 4. Multifocal intraocular malignant melanoma: report of two cases and review of the literature.
    Dithmar S, Völcker HE, Grossniklaus HE.
    Ophthalmology; 1999 Jul; 106(7):1345-8. PubMed ID: 10406619
    [Abstract] [Full Text] [Related]

  • 5. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R, Schulte KW, Vosberg H, Ruzicka T, Müller-Gärtner HW.
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [Abstract] [Full Text] [Related]

  • 6. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma].
    Löffler KU, Bräutigam P, Simon J, Althauser SR, Moser E, Witschel H.
    Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129
    [Abstract] [Full Text] [Related]

  • 7. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
    Michelot JM, Moreau MF, Veyre AJ, Bonafous JF, Bacin FJ, Madelmont JC, Bussiere F, Souteyrand PA, Mauclaire LP, Chossat FM.
    J Nucl Med; 1993 Aug; 34(8):1260-6. PubMed ID: 8326382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ultrasound biomicroscopy in the management of malignant melanoma of the iris.
    Katz NR, Finger PT, McCormick SA, Tello C, Ritch R, Sirota M, Kranz O.
    Arch Ophthalmol; 1995 Nov; 113(11):1462-3. PubMed ID: 7487612
    [No Abstract] [Full Text] [Related]

  • 11. An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma.
    John CS, Saga T, Kinuya S, Le N, Jeong JM, Paik CH, Reba RC, Varma VM, McAfee JG.
    Nucl Med Biol; 1993 Jan; 20(1):75-9. PubMed ID: 8461882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ultrasound biomicroscopy in management of malignant iris melanoma.
    Nordlund JR, Robertson DM, Herman DC.
    Arch Ophthalmol; 2003 May; 121(5):725-7. PubMed ID: 12742854
    [No Abstract] [Full Text] [Related]

  • 18. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Henker C, Bida B, Markwardt J, Schlag P.
    Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.